Frankfurt - Delayed Quote EUR
AlzeCure Pharma AB (publ) (AC6.F)
0.1755
-0.0015
(-0.85%)
At close: May 2 at 8:12:33 AM GMT+2
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 36.94M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| Unruh (Vincent Paul) Director (Independent) | Exercise at price 1.87 per share. | Direct | 280,830 | Dec 29, 2017 |
| Unruh (Vincent Paul) Director (Independent) | Exercise at price 0.82 per share. | Direct | 3,436 | Sep 28, 2017 |
| Phillpot (Robert William) Director (Executive) | Exercise at price 0.83 per share. | Direct | 129,099 | Aug 25, 2017 |
| Jasper (Leigh Matthew) Chief Executive Officer | Exercise at price 0.83 per share. | Direct | 183,238 | Aug 25, 2017 |
| Lewis (Adam) Non Executive Chairman | Exercise at price 0.83 per share. | Direct | 99,540 | Aug 24, 2017 |
| Perrett (Paul) Chief Operating Officer | -- | Direct | -- | Jun 30, 2017 |
| Koppelman (Paul) Chief Financial Officer | -- | Direct | -- | Jun 30, 2017 |
| Jasper (Leigh Matthew) Chief Executive Officer | -- | Direct | -- | Nov 25, 2016 |
| Phillpot (Robert William) Director (Executive) | -- | Direct | -- | Nov 25, 2016 |
| Phillpot (Robert William) Director (Executive) | Sale at price 4.61 per share. | Direct | 133,547 | Sep 16, 2016 |
| Jasper (Leigh Matthew) Chief Executive Officer | Sale at price 4.51 per share. | Direct | 230,518 | Sep 15, 2016 |
| Phillpot (Robert William) Director (Executive) | Sale at price 4.52 per share. | Direct | 130,961 | Sep 15, 2016 |
| Jasper (Leigh Matthew) Chief Executive Officer | Sale at price 4.47 per share. | Direct | 357,768 | Sep 14, 2016 |
| Phillpot (Robert William) Director (Executive) | Sale at price 4.50 per share. | Direct | 329,124 | Sep 14, 2016 |
| Jasper (Leigh Matthew) Chief Executive Officer | Sale at price 4.48 per share. | Direct | 179,384 | Sep 13, 2016 |
| Phillpot (Robert William) Director (Executive) | Sale at price 4.49 per share. | Direct | 152,246 | Sep 13, 2016 |
| Jasper (Leigh Matthew) Chief Executive Officer | Sale at price 4.52 per share. | Direct | 221,020 | Sep 9, 2016 |
| Jasper (Leigh Matthew) Chief Executive Officer | Exercise at price 0.71 per share. | Direct | 156,926 | Aug 30, 2016 |
| Phillpot (Robert William) Director (Executive) | Sale at price 4.93 per share. | Direct | 763,499 | Aug 30, 2016 |
| Jasper (Leigh Matthew) Chief Executive Officer | Sale at price 4.91 per share. | Direct | 98,216 | Aug 30, 2016 |
| Phillpot (Robert William) Director (Executive) | Exercise at price 0.72 per share. | Direct | 71,880 | Aug 29, 2016 |
| Jasper (Leigh Matthew) Chief Executive Officer | Sale at price 4.77 per share. | Direct | 95,344 | Aug 29, 2016 |
| Phillpot (Robert William) Director (Executive) | Sale at price 4.90 per share. | Direct | 146,874 | Aug 29, 2016 |
| Phillpot (Robert William) Director (Executive) | Sale at price 5.04 per share. | Direct | 251,845 | Aug 26, 2016 |
| Jasper (Leigh Matthew) Chief Executive Officer | Sale at price 4.92 per share. | Direct | 246,175 | Aug 26, 2016 |
| Hartnett (Rosemary) Director (Non-Executive) | Purchase at price 5.52 per share. | Direct | 11,041 | Aug 25, 2016 |
| Jasper (Leigh Matthew) Chief Executive Officer | Sale at price 5.38 per share. | Direct | 161,283 | Aug 25, 2016 |
| Jasper (Leigh Matthew) Chief Executive Officer | Sale at price 5.61 per share. | Direct | 123,420 | Aug 24, 2016 |
| Jasper (Leigh Matthew) Chief Executive Officer | Sale at price 5.64 per share. | Direct | 214,335 | Aug 24, 2016 |
| Perrett (Paul) Chief Financial Officer | -- | Direct | -- | Jun 30, 2016 |
| Lewis (Adam) Non Executive Chairman | Other at price 4.01 per share. | Direct | 12,884 | Apr 15, 2016 |
| Phillpot (Robert William) Director (Executive) | Other at price 4.01 per share. | Direct | 12,884 | Apr 15, 2016 |
| Jasper (Leigh Matthew) Chief Executive Officer | Other at price 4.01 per share. | Direct | 19,326 | Apr 15, 2016 |
| Yencken (Simon) Director (Independent) | Sale at price 4.71 per share. | Direct | 2,120,940 | Apr 4, 2016 |
| Yencken (Simon) Director (Independent) | Sale at price 4.25 per share. | Direct | 3,608,419 | Mar 24, 2016 |
| Phillpot (Robert William) Director (Executive) | Sale at price 3.98 per share. | Direct | 6,363,040 | Mar 17, 2016 |
| Jasper (Leigh Matthew) Chief Executive Officer | Sale at price 3.98 per share. | Direct | 5,726,736 | Mar 17, 2016 |
| Phillpot (Robert William) Director (Executive) | -- | Direct | -- | Mar 9, 2016 |
| Jasper (Leigh Matthew) Chief Executive Officer | -- | Direct | -- | Mar 9, 2016 |
| Phillpot (Robert William) Director (Executive) | -- | Direct | -- | Mar 9, 2016 |
| Jasper (Leigh Matthew) Chief Executive Officer | -- | Direct | -- | Mar 9, 2016 |
| Phillpot (Robert William) Director (Executive) | Other at price 1.64 per share. | Direct | 69,043 | Dec 2, 2015 |
| Jasper (Leigh Matthew) Chief Executive Officer | Other at price 1.64 per share. | Direct | 69,044 | Dec 2, 2015 |
| Phillpot (Robert William) Director (Executive) | Other at price 3.24 per share. | Direct | 427 | Nov 5, 2015 |
| Jasper (Leigh Matthew) Chief Executive Officer | Other at price 3.24 per share. | Direct | 427 | Nov 5, 2015 |
| Phillpot (Robert William) Director (Executive) | Other at price 3.01 per share. | Direct | 418 | Sep 30, 2015 |
| Jasper (Leigh Matthew) Chief Executive Officer | Other at price 3.01 per share. | Direct | 418 | Sep 30, 2015 |
| Jasper (Leigh Matthew) Chief Executive Officer | Exercise at price 0.68 per share. | Direct | 168,850 | Aug 31, 2015 |
| Phillpot (Robert William) Director (Executive) | Exercise at price 0.68 per share. | Direct | 84,425 | Aug 31, 2015 |
| Unruh (Vincent Paul) Director (Independent) | Exercise at price 0.80 per share. | Direct | 39 | Mar 11, 2015 |
Related Tickers
VX1.MU Vertex Pharmaceuticals Inc
439.25
-0.82%
VX1.HA Vertex Pharmaceuticals Inc
439.60
-0.92%
VX1.DU Vertex Pharmaceuticals Inc
440.35
-0.94%
0OT.DU Ocular Therapeutix Inc
7.67
+4.78%
HTD.SG Corcept Therapeutics Inc
64.08
+1.65%
VX1.BE Vertex Pharmaceuticals Inc
444.00
+0.90%
VX1.HM Vertex Pharmaceuticals Inc
439.65
-0.91%
VRTX.VI Vertex Pharmaceuticals Incorporated
440.30
-1.21%
1T3.BE Syndax Pharmaceuticals Inc
12.00
-4.00%
22UA.BE BioNTech SE
92.80
+1.98%